dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: Correlation with clinical disease activity

Clinical and Experimental Rheumatology

Volumn 14, Issue 5, 1996, Pages 543-550

  Filaci, G ^a   Grasso, I ^a   Contini, P ^a   Imro, M A ^a   Lanza, L ^a   Scudeletti, M ^a   Rossi, E ^b   Puppo, F ^a   Damasio, E ^b   Indiveri, F ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

anti DNA; cell mediated immunity; systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HISTONE; PREDNISONE;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIVISION; CELL LINE; CLONE CELLS; DEOXYRIBONUCLEASES; DISEASE PROGRESSION; DNA; FEMALE; FLOW CYTOMETRY; HISTONES; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; T-LYMPHOCYTES;

EID: 10144242672     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. LAMBERT PH, DIXON FJ: Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med 1968; 127: 507-22.
2. HOLMAN HR, DEICHER HR: The reaction of lupus erythematosus (LE) cell factor with deoxyribonucleoprotein of the cell nucleus. J Clin Invest 1959; 38: 2059-63.
3. SCHUR PH, SANDOSON J: Immunological factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1982; 278: 533-8.
4. HARLEY JB, SESTAK AL, WILLIS LG, FU M, HANSEN JA, REICHLIN M: A model for disease heterogeneity in systemic lupus erythematosus: relationship between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 1989; 32: 826-36.
5. HAHN BH, TSAO BP: Antibodies to DNA. In WALLACE DJ, HAHN BH (Eds.): Dubois' Systemic Lupus Erythematosus, Philadelphia, Lea & Febiger, 1993.
6. SHLOMCHIK MJ, MARSHAK-ROTHSTEIN A, WOLFOWICZ CB, ROTHSTEIN TL, WEIGERT MG: The role of clonal selection and somatic mutation in autoimmunity. Nature 1987; 328: 805-11.
7. SHLOMCHIK M, MASCELLI M, SHAN H, RADIC MZ, PISETSKY D, MARSHACK-ROTHSTEIN A, WEIGERT M: Anti DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171: 265-97.
8. RADIC MZ, MACKLE J, ERIKSON J, MOL C, ANDERSON WF, WEIGERT M: Residues that mediate DNA binding of autoimmune antibodies. J Immunol 1993; 150: 4966-77.
9. DALEY MD, MISENER V, OLEE T, CHEN PP, SIMINOVITCH KA: Genetic analysis of the variable region genes encoding a monospecific human natural anti-DNA antibody. Clin Exp Immunol 1993; 93: 11-8.
10. EILAT D: The role of germline gene expression and somatic mutation in the generation of autoantibodies to DNA. Molec Immunol 1990; 27: 203-10.
11. SHIVAKUMAR S, TSOKOS GC, DATTA SK: T cell receptor αβ expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 1989; 143: 103-12.
12. MURAKAMI M, KUMAGAIS, SUGITA M, IWAI K, IMURA H: In vitro induction of IgG anti-DNA antibody from high-density B-cells of systemic lupus erythematosus patients by an HLA-DR restricted T cell clone. Clin Exp Immunol 1992; 90: 245-50.
13. MOHAN C, ADAMS S, STANIK V, DATTA SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-81.
14. THEOCHARIS S, SFIKAKIS PP, LIPNICK RN, KLIPPLE GL, STINBERG AD, TSOKOS GC: Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1995; 74: 135-42.
15. DESAI-MEHTA A, MAO C, RAJAGOPALAN S, ROBINSON T, DATTA SK: Structure and specificity of T-cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995; 95: 531-41.
16. TAN EM, COHEN AS, FRIES JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. IMAI K, NATALI PG, KAY NE, WILSON BS, FERRONE S: Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells. Cancer Immunol Immunother 1982; 12: 159-63.
18. WEINER HL, MACKIN GA, MATSUI M, ORAV EJ, KHOURY SJ, DAWSON DM, HAFLER DA: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321-4.
19. MOLINARO GA, QUARANTA V, FERRONE S: Characterization of the specificity of DR monoclonal antibodies. Transplant Proc 1979; 11: 1748-54.
20. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH, the COMMITTEE ON PROGNOSIS STUDIES IN SLE: Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
21. BLANK M, MENDLOVIC S, MOZES E, COATES ARM. SHOENFELD Y: Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+). Clin Immunol Immunopathol 1991; 60:471-83.
22. BLANK M, BEN-BASSAT M, SHOENFELD Y: Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype. Cell Immunol 1991; 137: 474-86.
23. OKUBO M, YAMAMOTO K, KATO T, MATSUURA N, NISHIMAKI T, KASUKAWA R, ITO K, MIZUSHIMA Y, NISHIOKA K. Detection and epitope analysis of autoantigenreactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J Immunol 1993; 151: 1108-15.
24. LEWIN B: Genes-IV. 4th edition, Oxford University Press, New York and Cell Press, Cambridge, 1990; 75.
25. LEWIN B: Genes-IV. 4th edition, Oxford University Press, New York and Cell Press, Cambridge, 1990; 410.
26. PUCCETTI A, MADAIO MP, BELLESE G, MIGLIORINI P: Anti-DNA antibodies bind to DNase I. J Exp Med 1995; 181: 1797-804.
27. PEITSCH MC, POLZAR B, STEPHAN H, CROMPTON T, MACDONALD HR, MANNHERZ HG, TSCHOPP J: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 1993; 12: 371-7.
28. IOANNIDES CG, WHITESIDE TL: T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopath 1993; 66: 91-106.
29. SHUR PH, MEYER I, GAROVOY M, CARPENTER CB: Associations between systemic lupus erythematosus and the major histocompatibility complex: Clinical and immunological considerations. Clin Immunol Immunopathol 1982; 24: 263-75.
30. CONSTANT P, DAVODEAU F, PEYRAT M-A, POQUET Y, PUZO G, BONNEVILLE M, FOURNIÉ J-J: Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994; 264: 267-70.
31. TANAKA Y, MORITA CT, TANAKA Y, NIEVES E, BRENNER MB. BLOOM BR: Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995; 375: 155-8.
32. MAMULA MJ, FATENEJAD S, CRAFT J: B cell process and present lupus autoantigens that initiate autoimmune T cell response. J Immunol 1994; 152: 1453-61.
33. CASCIOLA-ROSEN LA. ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.